These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8736512

  • 1. Comparison of 201Tl, 99Tcm-MIBI and 131I imaging in the follow-up of patients with well-differentiated thyroid carcinoma.
    Uğur O, Kostakoğlu L, Caner B, Güler N, Gülaldi NC, Ozmen M, Uysal U, Elahi N, Erbengi G, Bejdik C.
    Nucl Med Commun; 1996 May; 17(5):373-7. PubMed ID: 8736512
    [Abstract] [Full Text] [Related]

  • 2. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation.
    Dadparvar S, Chevres A, Tulchinsky M, Krishna-Badrinath L, Khan AS, Slizofski WJ.
    Eur J Nucl Med; 1995 Nov; 22(11):1330-8. PubMed ID: 8575487
    [Abstract] [Full Text] [Related]

  • 3. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
    Seabold JE, Gurll N, Schurrer ME, Aktay R, Kirchner PT.
    J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid cancer--comparison study with 131I and 201Tl].
    Nagamachi S, Jinnouchi S, Nishii R, Flores LG, Nakahara H, Futami S, Tamura S, Toshimori H, Kawai K.
    Kaku Igaku; 2000 Mar; 37(2):89-98. PubMed ID: 10783567
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Routine 201Tl scintigraphy in the follow-up of patients with differentiated thyroid carcinoma: diagnostic accuracy and clinical impact.
    Hsu CC, Chen YW, Huang YF, Chuang YW.
    Nucl Med Commun; 2007 Sep; 28(9):681-7. PubMed ID: 17667746
    [Abstract] [Full Text] [Related]

  • 9. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S, Hadjieva T, Doldurova M, Stefanova S, Dudov A.
    J BUON; 2006 Sep; 11(4):511-8. PubMed ID: 17309186
    [Abstract] [Full Text] [Related]

  • 10. Comparison of 99Tcm-tetrofosmin with 201Tl and 131I in the detection of differentiated thyroid cancer metastases.
    Nishiyama Y, Yamamoto Y, Ono Y, Takahashi K, Nakano S, Satoh K, Ohkawa M, Tanabe M.
    Nucl Med Commun; 2000 Oct; 21(10):917-23. PubMed ID: 11130332
    [Abstract] [Full Text] [Related]

  • 11. Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
    Carril JM, Quirce R, Serrano J, Banzo I, Jiménez-Bonilla JF, Tabuenca O, Barquín RG.
    J Nucl Med; 1997 May; 38(5):686-92. PubMed ID: 9170428
    [Abstract] [Full Text] [Related]

  • 12. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma.
    Lorberboym M, Murthy S, Mechanick JI, Bergman D, Morris JC, Kim CK.
    J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199
    [Abstract] [Full Text] [Related]

  • 13. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
    Unal S, Menda Y, Adalet I, Boztepe H, Ozbey N, Alagöl F, Cantez S.
    J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M, Kasagi K, Misaki T, Matsumoto K, Iida Y, Ishimori T, Nakamoto Y, Higashi T, Saga T, Konishi J.
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS, Takeuchi R, Kasagi K, Misaki T, Miyamoto S, Iida Y, Hidaka A, Konishi J.
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [Abstract] [Full Text] [Related]

  • 18. Clinical importance of technetium-99m-methoxyisobutylisonitrile (MIBI) scintigraphy in differentiated thyroid carcinoma patients with elevated thyroglobulin levels and negative I-131 scanning results.
    Küçük NO, Külak HA, Aras G.
    Ann Nucl Med; 2006 Jul; 20(6):393-7. PubMed ID: 16922467
    [Abstract] [Full Text] [Related]

  • 19. Comparison of serum thyroglobulin, 131I and 201Tl scintigraphy in the postoperative follow-up of differentiated thyroid cancer.
    van Sorge-van Boxtel RA, van Eck-Smit BL, Goslings BM.
    Nucl Med Commun; 1993 May; 14(5):365-72. PubMed ID: 8510876
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.